Company Valuation: Orthocell Limited

Data adjusted to current consolidation scope
Fiscal Period: June 2022 2025 2026 2027 2028
Capitalization 1 79.84 285.9 246.9 - -
Change - - -13.65% - -
Enterprise Value (EV) 1 79.84 285.9 203.2 210.8 215.6
Change - - -28.94% 3.74% 2.28%
P/E ratio -8.62x -30.9x - - -
PBR - - - - -
PEG - - - - -
Capitalization / Revenue - - 17.8x 10.2x 5.17x
EV / Revenue - - 14.6x 8.75x 4.51x
EV / EBITDA - - -17.1x -30.1x 93.7x
EV / EBIT - - -15.4x -24x -2,156x
EV / FCF - - -16.3x -24.5x -38.5x
FCF Yield - - -6.15% -4.08% -2.6%
Dividend per Share 2 - - - - -
Rate of return - - - - -
EPS 2 -0.047 -0.038 - - -
Distribution rate - - - - -
Net sales 1 - - 13.9 24.1 47.8
EBITDA 1 - - -11.9 -7 2.3
EBIT 1 - - -13.2 -8.8 -0.1
Net income -9.107 -8.567 - - -
Net Debt 1 - - -43.7 -36.1 -31.3
Reference price 2 0.4050 1.1750 0.9100 0.9100 0.9100
Nbr of stocks (in thousands) 1,97,128 2,43,344 2,71,308 - -
Announcement Date 30/08/22 29/08/25 - - -
1AUD in Million2AUD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- 14.62x-17.07x - 17Cr
30.39x5.25x20.75x0.31% 20TCr
55.25x14.3x33.4x-.--% 17TCr
41.55x6.79x22.01x0.58% 15TCr
37.41x6.07x19.81x-.--% 11TCr
20.46x2.36x11.61x2.56% 5.46TCr
34.77x6.99x23.13x-.--% 4.57TCr
25.66x6.82x17.52x0.9% 3.96TCr
16.94x1.9x10.28x0.19% 3.68TCr
24.3x5.1x17.76x0.79% 3.67TCr
Average 31.86x 7.02x 15.92x 0.59% 8.57TCr
Weighted average by Cap. 36.89x 7.30x 22.22x 0.42%
See all sector valuations

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. OCC Stock
  4. Valuation Orthocell Limited